# Clay vs Lunit

Clay records 1,267,465 monthly visits with -2.7% month-over-month growth and Freemium, Free Trial, Contact for Pricing pricing. Lunit records 29,181 monthly visits with -12.8% growth and Contact for Pricing pricing.

| Metric | [Clay](https://openaitools.app/tool/clay-2-0) | [Lunit](https://openaitools.app/tool/lunit) |
| :--- | :--- | :--- |
| Website URL | https://www.clay.com | https://www.lunit.io/en |
| Categories | AI Agent, AI Lead Generation, AI Sales, AI CRM | AI Healthcare, AI Medical Diagnosis, AI Image Recognition |
| Pricing Model | Freemium, Free Trial, Contact for Pricing | Contact for Pricing |
| Monthly Visits | 1,267,465 | 29,181 |
| MoM Growth Rate | -2.7% | -12.8% |
| Primary Market | United States | South Korea |
| Direct Visits | 744,956 | 8,314 |
| Review Score | 4.7 | 4.6 |
| Saved Count | 2 | 1 |
| Supported Platforms | Website | Website |

## Clay

Clay brings together the three pillars of modern go-to-market work: data, reasoning, and activation. On the data side, its marketplace lets you buy and combine records from more than 200 providers under a single contract, with waterfall enrichment that queries multiple sources and keeps the best match. Signals and intent tracking surface job changes, promotions, and buying activity so you know when an account is actually in-market.

On top of that data layer, Clay runs agentic workflows. Its global agent and account agents research companies and people with AI, score and route leads, and write personalized outreach — and you can chain these steps into long-form automations or call them through the CLI and API. Because the same canvas handles enrichment, scoring, and messaging, teams stop stitching together spreadsheets, point tools, and scripts.

The activation layer is what makes the platform practical: sync targeted audiences to LinkedIn, Meta, and Google Ads, push enriched records back into your CRM with reverse ETL, or send personalized sequences through Clay's native sequencer. Clay is aimed at GTM ops, sales, marketing, and enterprise teams that want a repeatable, testable system rather than a pile of one-off campaigns.

**Pricing & Plans:** Clay uses flexible, plan-based pricing with a 14-day free trial and a free entry point for individuals getting started, while larger teams and enterprises are quoted based on seats, credits, and data usage. Contact Clay for detailed enterprise pricing.

- **Waterfall data enrichment:** Query 200+ data and AI providers from one contract and cascade across them to maximize coverage and accuracy.
- **Agentic research & scoring:** Clay's global agent and account agents research companies and people with AI, then score and route leads automatically.
- **Signals & intent tracking:** Monitor job changes, promotions, hiring activity, and other buying signals to target accounts at the right moment.
- **Workflow orchestration & CLI/API:** Chain enrichment, reasoning, and outreach into long-running workflows, or build programmatically with Clay's CLI, API, and MCP tooling.
- **Multi-channel activation:** Sync audiences to LinkedIn, Meta, and Google Ads, push data back to CRM via reverse ETL, and run personalized sequences natively.

**Strengths:** Unifies data enrichment, AI research, and multi-channel activation in a single platform; Marketplace with 200+ providers and waterfall enrichment delivers strong coverage; Powerful workflow automation with CLI, API, and MCP access for technical teams; Large, active community plus Clay University, livestreams, and education resources

**Limitations:** Steep learning curve — the flexible canvas can overwhelm new users; Credit-based data usage costs can scale quickly for high-volume teams; Enterprise pricing is quote-based, which complicates budget planning

[Profile (Markdown)](https://openaitools.app/tool/clay-2-0.md)

## Lunit

Lunit is a medical AI company headquartered in Seoul, South Korea, spun out of deep-learning research and focused squarely on oncology. Rather than chasing general-purpose healthcare AI, it has built two connected product families: one that helps clinicians find cancer earlier in imaging, and one that extracts quantitative biology from tissue to guide treatment and drug development. Its technology is used across a large international footprint spanning more than 10,000 customer sites in over 70 countries, with hundreds of peer-reviewed publications and industry partnerships behind the deployments.

On the screening side, the Lunit INSIGHT family analyzes mammograms and chest radiographs. Lunit INSIGHT MMG handles 2D mammography while Lunit INSIGHT DBT covers 3D breast tomosynthesis, both designed to flag suspicious regions so radiologists can prioritize the studies that need attention most. Lunit INSIGHT CXR does the same for chest X-rays. Around these detection engines Lunit has assembled program-level tooling: density assessment, risk assessment and risk pathways, live mammography reporting, quality management, analytics, and a patient hub, so a screening service can run AI as part of its routine rather than as an isolated experiment.

On the precision oncology side, the Lunit SCOPE portfolio analyzes pathology images. Lunit SCOPE IO quantifies the tumor microenvironment and immune cell infiltration, which matters for immunotherapy strategy, while the Lunit SCOPE IHC Suite supports immunohistochemistry quantification across markers such as HER2 and PD-L1, alongside a genotype prediction tool. These products are aimed at biopharma partners, clinical trial teams, and companion diagnostic development, where reproducible quantitative readouts are the bottleneck. Because Lunit sells to hospitals, screening programs, and pharmaceutical companies, pricing is quoted directly rather than published, and regulatory status differs by market.

**Pricing & Plans:** Contact for pricing. Lunit sells enterprise software and platform licenses to hospitals, screening programs, and biopharma partners, so commercial terms and deployment costs are quoted directly through its sales team. No public price list is offered.

- **Lunit INSIGHT MMG and DBT:** Deep-learning analysis of 2D and 3D mammography that marks suspicious lesions to help radiologists detect breast cancer earlier and reduce missed findings.
- **Lunit INSIGHT CXR:** Chest X-ray analysis that highlights potential abnormalities such as nodules and other findings, supporting faster triage in high-volume radiology workflows.
- **Lunit SCOPE IO:** Tumor microenvironment analysis that quantifies tumor-infiltrating lymphocytes and immune phenotypes from pathology slides, informing immunotherapy research.
- **Lunit SCOPE IHC Suite:** AI-assisted immunohistochemistry quantification covering HER2, PD-L1, and other markers, including uIHC and a gene-expression prediction tool for standardized scoring.
- **Screening analytics and workflow tools:** Live mammography reporting, risk assessment, risk pathways, quality management, and patient-facing tools that embed AI into the wider screening program.

**Strengths:** Clinically validated radiology AI with documented regulatory clearances and published evidence; Covers two ends of the cancer pathway — screening detection and precision oncology biomarkers — in one vendor relationship; Wide real-world adoption across many countries, which means integrations and workflow lessons already exist; Strong research output and biopharma partnerships support credibility for trial and CDx work

[Profile (Markdown)](https://openaitools.app/tool/lunit.md)

## Frequently Asked Questions

### How do Clay and Lunit compare in monthly traffic?

Clay has 1,267,465 monthly visits, while Lunit has 29,181. Traffic estimates describe audience size, not product quality.

### How do their growth rates compare?

Clay has a month-over-month growth rate of -2.7%; Lunit has -12.8%.

### How does pricing compare?

Clay: Freemium, Free Trial, Contact for Pricing. Clay uses flexible, plan-based pricing with a 14-day free trial and a free entry point for individuals getting started, while larger teams and enterprises are quoted based on seats, credits, and data usage. Contact Clay for detailed enterprise pricing. Lunit: Contact for Pricing. Contact for pricing. Lunit sells enterprise software and platform licenses to hospitals, screening programs, and biopharma partners, so commercial terms and deployment costs are quoted directly through its sales team. No public price list is offered.

## Alternatives

| # | Tool Name | Monthly Visits | MoM Growth Rate | Pricing Model | Summary | Profile (Markdown) |
| :--- | :--- | :--- | :--- | :--- | :--- | :--- |
| 1 | [Zapier](https://openaitools.app/tool/zapier-com) | 5,065,248 | +0.4% | Freemium, Free Trial, Paid | Automate work across thousands of apps — no code required | [.md](https://openaitools.app/tool/zapier-com.md) |
| 2 | [Instantly](https://openaitools.app/tool/instantly) | 2,336,279 | +6% | Paid, Contact for Pricing | Combines cold email campaigns with verified leads, but focuses more on outreach execution than deep enrichment. | [.md](https://openaitools.app/tool/instantly.md) |
| 3 | [Outreach](https://openaitools.app/tool/outreach) | 958,599 | +0.4% | Contact for Pricing | AI agents that work the revenue lifecycle alongside your sellers | [.md](https://openaitools.app/tool/outreach.md) |
| 4 | [Smartlead](https://openaitools.app/tool/smartlead-ai) | 952,377 | +4.3% | Free Trial, Paid | Excels at cold email deliverability and automation, but offers fewer options for complex multi-source data enrichment. | [.md](https://openaitools.app/tool/smartlead-ai.md) |
| 5 | [Success.ai](https://openaitools.app/tool/success-ai) | 547,073 | +6.3% | Freemium, Free Trial | Offers lead generation and email warmup features, but lacks the deep data orchestration and scraping flexibility. | [.md](https://openaitools.app/tool/success-ai.md) |
| 6 | [Gumloop](https://openaitools.app/tool/gumloop) | 379,557 | -21.1% | Freemium, Paid, Contact for Pricing | Build, share, and control AI agents that actually do the work | [.md](https://openaitools.app/tool/gumloop.md) |
| 7 | [Copy.ai](https://openaitools.app/tool/copy-ai) | 344,338 | -14.8% | Freemium, Paid | Provides unified sales prospecting workflows, but is less flexible for custom spreadsheet-based data enrichment. | [.md](https://openaitools.app/tool/copy-ai.md) |
| 8 | [ScanSkinAI](https://openaitools.app/tool/scanskinai) | 265,770 | -10.9% | Freemium, Paid | Free AI skin and mole scanning with optional dermatologist review | [.md](https://openaitools.app/tool/scanskinai.md) |
| 9 | [Overjet](https://openaitools.app/tool/overjet-ai) | 256,150 | +12.6% | Contact for Pricing | FDA-cleared dental AI for diagnostics, imaging, and insurance workflow | [.md](https://openaitools.app/tool/overjet-ai.md) |
| 10 | [Pearl](https://openaitools.app/tool/hellopearl-com) | 221,155 | -7.6% | Contact for Pricing | FDA-cleared dental AI for sharper diagnosis and a smoother front office | [.md](https://openaitools.app/tool/hellopearl-com.md) |

---
Source: https://openaitools.app/compare/clay-2-0-vs-lunit

More Markdown: [Categories](https://openaitools.app/categories.md) · [Traffic rankings](https://openaitools.app/rankings.md) · [llms.txt](https://openaitools.app/llms.txt)
